[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353267-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353267-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","m-1a-mediated-regulation-of-birc2-mrna-stability-drives-apoptosis-evasion-and-tumor-progression-in-liver-cancer","m 1A-mediated regulation of BIRC2 mRNA stability drives apoptosis evasion and tumor progression in liver cancer","","Liver cancer is a major cause of cancer-related death, driven by uncontrolled proliferation and apoptosis evasion. N1-methyladenosine (m1A) is a widespread RNA modification in cancer, but its function in liver cancer is unclear. Reduced m1A levels in liver cancer tissues promote apoptosis evasion. ALKBH3 regulates apoptosis by controlling BIRC2 expression: its loss destabilizes BIRC2 mRNA via m1A changes at A98/99/100 in the 5'-UTR, enhancing YTHDF3/CNOT1–XRN2-mediated degradation, supported by in vitro, in vivo, and clinical evidence.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/m-1a-mediated-regulation-of-birc2-mrna-stability-drives-apoptosis-evasion-and-tumor-progression-in-liver-cancer/353267/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/m-1a-mediated-regulation-of-birc2-mrna-stability-drives-apoptosis-evasion-and-tumor-progression-in-liver-cancer/353267.png","ImageObject",300,407,{"name":42,"@type":43},"Guten tag","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What key change in m1A levels is observed in liver cancer?","Question",{"text":63,"@type":64},"m1A levels are significantly reduced in liver cancer tissues, which contributes to apoptosis evasion in liver cancer cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does ALKBH3 affect BIRC2 and apoptosis?",{"text":68,"@type":64},"ALKBH3 regulates apoptosis by modulating BIRC2 expression; ALKBH3 depletion destabilizes BIRC2 mRNA by promoting its degradation.",{"name":70,"@type":61,"acceptedAnswer":71},"What role do m1A modifications at BIRC2 5'-UTR positions A98/99/100 play?",{"text":72,"@type":64},"These m1A modifications enhance interaction between BIRC2 mRNA and the YTHDF3/CNOT1–XRN2 complex, thereby driving mRNA degradation and influencing tumor progression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353267,1790532825,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},687212321768,"https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nm 1A-mediated regulation of BIRC2 mRNA stability drives apoptosis evasion and tumor progression in liver cancer  \nYingmin Wu 1,2,3,4,7, Shenjie Zhang 1,7, Shilong Zhang 1,5,7, Jieyu Lu2,3, Yuntao Yang2,3, Zhirui Zeng 1,2,3, Shan Lei2,3, Rui Mi1, Yewei Zhang1, Lichen Ge 6 ✉, Tengxiang Chen 1,2,3,4 ✉ and Haiyang Li 1,4 ✉  \n© The Author(s) 2026  \n\n|  | Liver cancer remains one of the leading causes of cancer-related mortality worldwide, with its progression driven by uncontrolled cell proliferation and evasion of apoptosis. N1-methyladenosine (m1A) is a prevalent RNA modiﬁcation implicated in cancer progression, yet its role in liver cancer remains unclear. Here, we report a signiﬁcant reduction in m1A levels in liver cancer tissues, which contributes to apoptosis evasion in liver cancer cells. We demonstrate that ALKBH3, an m1A demethylase, regulates apoptosis by modulating BIRC2 expression. Speciﬁcally, ALKBH3 depletion destabilizes BIRC2 mRNA by promoting its degradation, facilitated by m1A modiﬁcations at positions A98/99/100 in the 5'-UTR of BIRC2 . These modiﬁcations enhance the interaction between BIRC2 mRNA and the YTHDF3/CNOT1–XRN2 complex, thereby driving mRNA degradation. In vitro, in vivo, and clinical analyses validate the critical role of the m1A/BIRC2 axis in regulating apoptosis and tumor progression in liver cancer. Our ﬁndings underscore the therapeutic potential of targeting the m1A/BIRC2 axis to overcome apoptosis resistance in liver cancer, offering new |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| avenues for intervention in this malignancy. |  |  |\n|  | Cell Death and Disease (2026)17:630; [https://doi.org/10.1038/s41419-026-08731-z](https://doi.org/10.1038/s41419-026-08731-z) |  |\n|  |  |  |\n\nINTRODUCTION  \nPrimary liver cancer is the seventh most commonly diagnosed cancer worldwide and the second leading cause of cancer-related mortality, with both incidence and mortality rates continuing to show a signiﬁcant upward trend across diverse populations [1] . Asthe predominant form of primary liver malignancy, accounting for approximately 85% of all cases, it poses a signiﬁcant clinical and socioeconomic burden, especially in regions with high prevalence of hepatitis B or C virus infection [2, 3] . Despite advances in treatment options, the prognosis for liver cancer remains poor, largely due to late diagnosis and an incomplete understanding of its molecular pathogenesis. Therefore, elucidating novel regulatory mechanisms driving liver cancer progression is urgently needed.  \nEmerging evidence highlights the pivotal role of epitranscriptomic reprogramming in liver cancer development and metastatic progression [4] . Among various RNA modiﬁcations, N1-methyladenosine (m1A) has garnered increasing attention as a dynamic post-transcriptional regulator [5] . This reversible modiﬁcation, characterized by methyl group addition at the adenosine N1 position, induces local RNA structural perturbations by disrupting canonical base pairing [6, 7] . Similar to the wellcharacterized N6-methyladenosine (m6A) modiﬁcation, m1A is dynamically regulated by methyltransferases (writers: TRMT6/61A/ 61B/10C, NML), demethylases (erasers: ALKBH1/3/7, FTO), and  \nrecognition proteins (readers: YTHDF1–3, YTHDC1) [7–10] . Notably, ALKBH3 serves as the principal eraser responsible for m1Ademethylation on mRNA [10] . These regulatory components collectively orchestrate m1A-mediated control of mRNA splicing [11], structural conformation [6], translational efﬁciency [5, 7, 11, 12], and degradation kinetics [13–15] .  \nDysregulation of m1A homeostasis has been implicated in multiple oncogenic processes. Our previous investigations demonstrated that m1A modulates tRNA-derived fragment (tDR) biogenesis to regulate cancer cell proliferation, clonogenicity, invasiveness, and apoptosis [9], while also suppressing glyc","cbCain2N4mffroJn","https://ap.wps.com/l/cbCain2N4mffroJn","pdf",5641922,16,"English","# Introduction\n## m1A and RNA epitranscriptomics in liver cancer\n## m1A regulators and mechanistic gaps\n## Apoptosis evasion as a therapeutic barrier","[{\"question\":\"What key change in m1A levels is observed in liver cancer?\",\"answer\":\"m1A levels are significantly reduced in liver cancer tissues, which contributes to apoptosis evasion in liver cancer cells.\"},{\"question\":\"How does ALKBH3 affect BIRC2 and apoptosis?\",\"answer\":\"ALKBH3 regulates apoptosis by modulating BIRC2 expression; ALKBH3 depletion destabilizes BIRC2 mRNA by promoting its degradation.\"},{\"question\":\"What role do m1A modifications at BIRC2 5'-UTR positions A98/99/100 play?\",\"answer\":\"These m1A modifications enhance interaction between BIRC2 mRNA and the YTHDF3/CNOT1–XRN2 complex, thereby driving mRNA degradation and influencing tumor progression.\"}]","m 1A-mediated regulation of BIRC2 mRNA stability drives apoptosis evasion and tumor progression in liver cancer | PDF",1790103963,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4703b3843c822b3fe2f0eb66d9c10b41.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6bf275416ed83b35005f39c66ce9c665.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c27014ff1ec5f677b5c3e781473b7fd.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b43e061c65c6d34fc23c2fb535499ee.webp",980,1301]